Woodley Farra Manion Portfolio Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,488
Closed -$237K 125
2025
Q4
$237K Buy
+2,488
New +$244K 0.01% 106
2025
Q3
Sell
-1,988
Closed -$214K 119
2025
Q2
$214K Sell
1,988
-66
-3% -$6.68K 0.01% 110
2025
Q1
$207K Buy
+2,054
New +$207K 0.01% 109
2020
Q3
Sell
-3,545
Closed -$124K 125
2020
Q2
$124K Sell
3,545
-82
-2% -$2.95K 0.01% 94
2020
Q1
$118K Sell
3,627
-20
-0.5% -$781 0.01% 97
2019
Q4
$165K Buy
+3,647
New +$153K 0.02% 98

Other funds holding BSX

Woodley Farra Manion Portfolio Management's BSX Position: Q1 2026 in Review

Woodley Farra Manion Portfolio Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,488 shares — an estimated $237K sold.

Woodley Farra Manion Portfolio Management first reported a position in BSX in Q4 2019 and held it in 6 quarters. The position peaked at $237K in Q4 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Woodley Farra Manion Portfolio Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Woodley Farra Manion Portfolio Management sold 2,488 Boston Scientific shares in Q1 2026, an estimated $237K.
  • Woodley Farra Manion Portfolio Management first reported a position in Boston Scientific in Q4 2019 and held it in 6 quarters.
  • Woodley Farra Manion Portfolio Management's Boston Scientific position peaked at $237K in Q4 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q1 2026, filed 8 May 2026.